Skip to content
2000
Volume 31, Issue 38
  • ISSN: 1381-6128
  • E-ISSN: 1873-4286

Abstract

Objective

This study investigates the potential targets and mechanisms of Paeoniae Radix Rubra (PRR) in treating Venous Thrombosis (VTE) by employing network pharmacology, bioinformatics analysis, and molecular docking validation.

Methods

Active components of PRR were identified TCMSP. VTE-related genes were screened from GEO datasets, and WGCNA analyzed key modules. A Protein-Protein Interaction (PPI) network was constructed using Cytoscape, followed by immune infiltration analysis. Core targets were functionally annotated GO and KEGG pathways. Molecular docking and molecular dynamics simulations validated interactions between PRR components and core targets.

Results

A total of 30 active components of PRR and 21 potential targets for the treatment of VTE were identified. From the PPI network, 10 hub genes were screened. KEGG pathway enrichment analysis demonstrated that the target genes were significantly enriched in pathways, such as the cGMP-PKG signaling pathway, B cell receptor signaling pathway, Th1 and Th2 cell differentiation, and IL-17 signaling pathway. Molecular docking results revealed that MAPK1, NFATC1, and SELP all had good affinity with the screened active components. Among them, MAPK1 and beta-sitosterol exhibited the highest binding energy of -8.73 kcal/mol. Molecular dynamics simulation results from RMSD, RMSF, HBond, and SASA analyses indicated that the beta-sitosterol-MAPK1 complex maintained good stability.

Conclusion

Through this study, it was found that PRR may act on targets, such as MAPK1 and NFATC1, through components like beta-sitosterol and Stigmasterol. Among them, the complex (beta-sitosterol - MAPK1) may be the key active component that plays a role in treating VTE.

Loading

Article metrics loading...

/content/journals/cpd/10.2174/0113816128374345250521115849
2025-11-01
2025-09-12
Loading full text...

Full text loading...

References

  1. TimpJ.F. LijferingW.M. RosendaalF.R. CessieL.S. CannegieterS.C. Risk prediction of recurrent venous thrombosis; where are we now and what can we add?J. Thromb. Haemost.20191791527153410.1111/jth.14535 31188515
    [Google Scholar]
  2. OlafM. CooneyR. Deep venous thrombosis.Emerg. Med. Clin. North Am.201735474377010.1016/j.emc.2017.06.003 28987427
    [Google Scholar]
  3. IñurrietaA. PedrajasJ. NúñezM. Outcomes beyond the third month of anticoagulation in patients aged >75 years with a first episode of unprovoked venous thromboembolism.TH Open201824e428e43610.1055/s‑0038‑1676359 31249971
    [Google Scholar]
  4. RodgerM.A. GalL.G. Who should get long-term anticoagulant therapy for venous thromboembolism and with what?Blood Adv.20182213081308710.1182/bloodadvances.2018020230 30425073
    [Google Scholar]
  5. SharmaH. AfzalS. LeickJ. WernerN. DoshiS.N. NadirM.A. Antithrombotic therapy following transcatheter aortic valve intervention.Pharmacol. Ther.202325010850910.1016/j.pharmthera.2023.108509 37572882
    [Google Scholar]
  6. TangL. XuB. Observational study of traditional chinese medicine in treating venous thrombosis: Analysis of 88 cases.Wid J Int Tradit West Med20094354357
    [Google Scholar]
  7. ZhangX. LiuM. LiuC. ZhangL. Overview of traditional Chinese medicine in preventing venous thromboembolism.J Shandong Uni Tradit Chin202347116120
    [Google Scholar]
  8. CuiL. MiaoL. Analysis of traditional chinese medicine anti-thrombotic medication patterns based on data mining and network pharmacology.Chin. Tradit. Herbal Drugs20215210631072
    [Google Scholar]
  9. PressCMT Pharmacopoeia of the People's Republic of China.Republic of China: Pharmacopoeia of the People's202019
    [Google Scholar]
  10. ZhaoJ.R. YangT. ZaoN. Advancements in the study of antithrombotic components and associated mechanisms in red peony.Zhongguo Zhongyiyao Xinxi Zazhi202128137140
    [Google Scholar]
  11. LuZ. YeY. LiuY. Aqueous extract of Paeoniae Radix Rubra prevents deep vein thrombosis by ameliorating inflammation through inhibiting GSK3β activity.Phytomedicine20219215376710.1016/j.phymed.2021.153767 34597905
    [Google Scholar]
  12. YaoX. The application of Red Peony Root and Ligusticum wallichii in rats with Blood Stasis Syndrome. In:2013
    [Google Scholar]
  13. WuL.F. WangZ.M. HeK.Q. Overview of the chemical components and pharmacological effects of red peony.Zhongguo Shiyan Fangjixue Zazhi202127198206
    [Google Scholar]
  14. XieP. CuiL. ShanY. KangW. Antithrombotic effect and mechanism of radix paeoniae rubra.BioMed Res. Int.201720171910.1155/2017/9475074 28299338
    [Google Scholar]
  15. SaimaL.S. LathaS. SharmaR. KumarA. Role of network pharmacology in prediction of mechanism of neuroprotective compounds.Methods Mol. Biol.2024276115917910.1007/978‑1‑0716‑3662‑6_13 38427237
    [Google Scholar]
  16. WuJ. HuangH. ChenG. Integration of network pharmacology, bioinformatics and experimental verification strategy to discover the pharmacological mechanisms of mogroside acts against pharyngitis.J. Ethnopharmacol.202534411949910.1016/j.jep.2025.119499 39956299
    [Google Scholar]
  17. LiX. WeiS. NiuS. Network pharmacology prediction and molecular docking-based strategy to explore the potential mechanism of Huanglian Jiedu Decoction against sepsis.Comput. Biol. Med.202214410538910.1016/j.compbiomed.2022.105389 35303581
    [Google Scholar]
  18. LeiH. SuH. CaoL. Investigating Xiaochaihu Decoction’s fever-relieving mechanism via network pharmacology, molecular docking, dynamics simulation, and experiments.Anal. Biochem.202469411562910.1016/j.ab.2024.115629 39069245
    [Google Scholar]
  19. SinghR. KumarA. LatherV. SharmaR. PanditaD. Identification of novel signal of Raynaud’s phenomenon with Calcitonin Gene-Related Peptide (CGRP) antagonists using data mining algorithms and network pharmacological approaches.Expert Opin. Drug Saf.202423223123810.1080/14740338.2023.2248877 37594041
    [Google Scholar]
  20. AryaS. KhareR. GargI. SrivastavaS. Gene expression profiling in Venous thromboembolism: Insights from publicly available datasets.Comput. Biol. Chem.202411310824610.1016/j.compbiolchem.2024.108246 39413445
    [Google Scholar]
  21. WangP. ZhengL. QiX. Contribution of FOS in neutrophils to venous thromboembolism via miR ‐144 based on bioinformatic prediction and validation.J. Cell. Mol. Med.20242811e1837010.1111/jcmm.18370 38818568
    [Google Scholar]
  22. ZhouJ. GuoY. LiuX. YuanW. Bioinformatics analysis identifies key secretory protein-encoding differentially expressed genes in adipose tissue of metabolic syndrome.Adipocyte2025141244624310.1080/21623945.2024.2446243 39819282
    [Google Scholar]
  23. LiuY. ZhangJ. HanQ. LiY. XueY. LiuX. Identification of biomarkers associated with macrophage polarization in diabetic cardiomyopathy based on bioinformatics and machine learning approaches.Life Sci.202536412344310.1016/j.lfs.2025.123443 39914590
    [Google Scholar]
  24. XiuM. LiuY. ChenG. HuC. KuangB. Identifying hub genes, key pathways and immune cell infiltration characteristics in pediatric and adult ulcerative colitis by integrated bioinformatic analysis.Dig. Dis. Sci.20216693002301410.1007/s10620‑020‑06611‑w 32974809
    [Google Scholar]
  25. TiwariP. AliS.A. PuriB. KumarA. DatusaliaA.K. Tinospora cordifolia Miers enhances the immune response in mice immunized with JEV-vaccine: A network pharmacology and experimental approach.Phytomedicine202311915497610.1016/j.phymed.2023.154976 37573808
    [Google Scholar]
  26. DalalV. DhankharP. SinghV. Structure-based identification of potential drugs against FmtA of Staphylococcus aureus: virtual screening, molecular dynamics, MM-GBSA, and QM/MM.Protein J.202140214816510.1007/s10930‑020‑09953‑6 33421024
    [Google Scholar]
  27. GuptaM. SharmaR. KumarA. Docking techniques in pharmacology: How much promising?Comput. Biol. Chem.20187621021710.1016/j.compbiolchem.2018.06.005 30067954
    [Google Scholar]
  28. WangY. ZhangY. WangY. Using network pharmacology and molecular docking to explore the mechanism of Shan Ci Gu (Cremastra appendiculata) against non-small cell lung cancer.Front Chem.2021968286210.3389/fchem.2021.682862 34178945
    [Google Scholar]
  29. KumariR. DalalV. Identification of potential inhibitors for LLM of Staphylococcus aureus: Structure-based pharmacophore modeling, molecular dynamics, and binding free energy studies.J. Biomol. Struct. Dyn.202240209833984710.1080/07391102.2021.1936179 34096457
    [Google Scholar]
  30. LiuY. ChenH. YangG. FengF. Metabolomics and serum pharmacochemistry combined with network pharmacology uncover the potential effective ingredients and mechanisms of Yin-Chen-Si-Ni Decoction treating ANIT-induced cholestatic liver injury.J. Ethnopharmacol.202433511871310.1016/j.jep.2024.118713 39163894
    [Google Scholar]
  31. LiuJ. LiuJ. TongX. Network pharmacology prediction and molecular docking-based strategy to discover the potential pharmacological mechanism of Huai Hua San against ulcerative colitis.Drug Des. Devel. Ther.2021153255327610.2147/DDDT.S319786 34349502
    [Google Scholar]
  32. ReenaK. RaviR. SeemaR.P. VikramD. Structural-based virtual screening and identification of novel potent antimicrobial compounds against YsxC of Staphylococcus aureus.J. Mol. Struct.2022125513247610.1016/j.molstruc.2022.132476
    [Google Scholar]
  33. DuffettL. Deep Venous Thrombosis.Ann. Intern. Med.20221759ITC129ITC14410.7326/AITC202209200 36095313
    [Google Scholar]
  34. ZC H, Y L. Research progress on venous thromboembolism risk assessment in orthopedic surgery patients.J Med Res Combat Trauma Care201528445448
    [Google Scholar]
  35. MaY.H. YangY. LiJ.H. NDUFB11 and NDUFS3 regulate arterial atherosclerosis and venous thrombosis: Potential markers of atherosclerosis and venous thrombosis.Medicine202310246e3613310.1097/MD.0000000000036133 37986300
    [Google Scholar]
  36. JiL. SongT. GeC. Identification of bioactive compounds and potential mechanisms of scutellariae radix-coptidis rhizoma in the treatment of atherosclerosis by integrating network pharmacology and experimental validation.Biomed. Pharmacother.202316511521010.1016/j.biopha.2023.115210 37499457
    [Google Scholar]
  37. LeeW. KuS.K. BaeJ.S. Antiplatelet, anticoagulant, and profibrinolytic activities of baicalin.Arch. Pharm. Res.201538589390310.1007/s12272‑014‑0410‑9 24849036
    [Google Scholar]
  38. WuZ. WangJ. ZhouS. LinM. WangX. Baicalin inhibits platelet aggregation and protects lung tissue in a rat model of acute pulmonary embolism via the notch signaling pathway.China Pharmacy20203110911097
    [Google Scholar]
  39. LuX. MaX. WangJ. Research progress on chemical constituents of Paeoniae Rubra Radix and their pharmacological effects.Chin. Tradit. Herbal Drugs201546595602
    [Google Scholar]
  40. ZhaoX. HeS. Research progress on preparation technology and pharmacological effects of total paeony glycoside.Liaoning Zhongyiyao Daxue Xuebao20242649
    [Google Scholar]
  41. WuL. LiJ. ZhangT. TaoF. LiuW. The anti-inflammatory effect of stigmasterol was studied based on network pharmacology and cell experiments.Zhongchengyao202244609615
    [Google Scholar]
  42. GuoJ. LiK. LinY. LiuY. Protective effects and molecular mechanisms of tea polyphenols on cardiovascular diseases.Front. Nutr.202310120237810.3389/fnut.2023.1202378 37448666
    [Google Scholar]
  43. OakM-H. BedouiJ.E. MadeiraS.V.F. ChalupskyK. Schini-KerthV.B. Delphinidin and cyanidin inhibit PDGFAB‐induced VEGF release in vascular smooth muscle cells by preventing activation of p38 MAPK and JNK.Br. J. Pharmacol.2006149328329010.1038/sj.bjp.0706843 16921400
    [Google Scholar]
  44. KrgaI. VidovicN. MilenkovicD. Effects of anthocyanins and their gut metabolites on adenosine diphosphate-induced platelet activation and their aggregation with monocytes and neutrophils.Arch. Biochem. Biophys.2018645344110.1016/j.abb.2018.03.016 29555206
    [Google Scholar]
  45. SariD. CairnsJ. SafitriA. FatchiyahF. Virtual Prediction of the Delphinidin-3-O-glucoside and Peonidin-3-O-glucoside as Anti-inflammatory of TNF- and #945; Signaling.Acta Inform. Med.201927315215710.5455/aim.2019.27.152‑157 31762569
    [Google Scholar]
  46. TangS.X. Improvement of purple sweet potato root anthocyanins on adriamycin-induced cardiotoxicity.Yangzhou University2021 https://link.cnki.net/doi/10.27441/d.cnki.gyzdu.2021.001101
    [Google Scholar]
  47. SunZ.F. Studies on flavonoids composition of the peony and its antioxidant activity analysis.Northwest A&F University2015
    [Google Scholar]
  48. ShuK.X. Isolation and identification of the antioxidant components from the flowers of Paeonia lactiflora.Shandong Normal University2013
    [Google Scholar]
  49. SongL.M. Structure and free radical scavenging effect of peony AE and gallic hydroxypaeoniflorin in peony barkInter.J. Tradit. Chin. Med.200213031
    [Google Scholar]
  50. DingY. ZhangB. ZhouK. Dietary ellagic acid improves oxidant-induced endothelial dysfunction and atherosclerosis: Role of Nrf2 activation.Int. J. Cardiol.2014175350851410.1016/j.ijcard.2014.06.045 25017906
    [Google Scholar]
  51. CuiX. DanC. ZhangD. MaC. Investigation on in vivo antithrombic effect of typical plant phenolic compounds.J Inner Mongolia Unive202354372381
    [Google Scholar]
  52. WicikZ. CzajkaP. EyiletenC. The role of miRNAs in regulation of platelet activity and related diseases - a bioinformatic analysis.Platelets20223371052106410.1080/09537104.2022.2042233 35285386
    [Google Scholar]
  53. LiuG. XieW. HeA.D. Antiplatelet activity of chrysin via inhibiting platelet αIIbβ3‐mediated signaling pathway.Mol. Nutr. Food Res.20166091984199310.1002/mnfr.201500801 27006308
    [Google Scholar]
  54. PaskalW. KopkaM. StachuraA. Single dose of n-acetylcysteine in local anesthesia increases expression of HIF1α, MAPK1, TGFβ1 and growth factors in rat wound healing.Int. J. Mol. Sci.20212216865910.3390/ijms22168659
    [Google Scholar]
  55. EyiletenC. WicikZ. RosaD.S. MicroRNAs as diagnostic and prognostic biomarkers in ischemic stroke—a comprehensive review and bioinformatic analysis.Cells201871224910.3390/cells7120249 30563269
    [Google Scholar]
  56. KongP. CuiZ.Y. HuangX.F. ZhangD.D. GuoR.J. HanM. Inflammation and atherosclerosis: Signaling pathways and therapeutic intervention.Signal Transduct. Target. Ther.20227113110.1038/s41392‑022‑00955‑7 35459215
    [Google Scholar]
  57. YooJ. PerezR.C.E. NieW. Sinnett-SmithJ. RozengurtE. TNF-α and LPA promote synergistic expression of COX-2 in human colonic myofibroblasts: Role of LPA-mediated transactivation of upregulated EGFR.BMC Gastroenterol.20131319010.1186/1471‑230X‑13‑90 23688423
    [Google Scholar]
  58. BiY. LiangH. HanX. β-sitosterol suppresses lps‐induced cytokine production in human umbilical vein endothelial cells via MAPKs and NF-κ B signaling pathway.Evid. Based Complement. Alternat. Med.202320231924109010.1155/2023/9241090 36636603
    [Google Scholar]
  59. BuS.Y. LernerM. StoeckerB.J. Dried plum polyphenols inhibit osteoclastogenesis by downregulating NFATc1 and inflammatory mediators.Calcif. Tissue Int.200882647548810.1007/s00223‑008‑9139‑0 18509698
    [Google Scholar]
  60. ShinS.Y. KimM.W. ChoK.H. NguyenL.K. Coupled feedback regulation of nuclear factor of activated T-cells (NFAT) modulates activation-induced cell death of T cells.Sci. Rep.2019911063710.1038/s41598‑019‑46592‑z 31337782
    [Google Scholar]
  61. MócsaiA. AbramC.L. JakusZ. HuY. LanierL.L. LowellC.A. Integrin signaling in neutrophils and macrophages uses adaptors containing immunoreceptor tyrosine-based activation motifs.Nat. Immunol.20067121326133310.1038/ni1407 17086186
    [Google Scholar]
  62. HoganP.G. ChenL. NardoneJ. RaoA. Transcriptional regulation by calcium, calcineurin, and NFAT.Genes Dev.200317182205223210.1101/gad.1102703 12975316
    [Google Scholar]
  63. FuZ. LiQ. LuL. LiY. Relationship of serum ANGPTL3 and NFATc1 levels with the severity and prognosis in cerebral infarction patients.J Pract Med20244014071411
    [Google Scholar]
  64. GengJ.G. BevilacquatM.P. MooreK.L. Rapid neutrophil adhesion to activated endothelium mediated by GMP-140.Nature1990343626075776010.1038/343757a0 1689464
    [Google Scholar]
  65. McEverR.P. Selectins: initiators of leucocyte adhesion and signalling at the vascular wall.Cardiovasc. Res.2015107333133910.1093/cvr/cvv154 25994174
    [Google Scholar]
  66. LeyK. LaudannaC. CybulskyM.I. NoursharghS. Getting to the site of inflammation: the leukocyte adhesion cascade updated.Nat. Rev. Immunol.20077967868910.1038/nri2156 17717539
    [Google Scholar]
  67. CeliA. PellegriniG. LorenzetR. P-selectin induces the expression of tissue factor on monocytes.Proc. Natl. Acad. Sci. USA199491198767877110.1073/pnas.91.19.8767 7522321
    [Google Scholar]
  68. SawamiphakS. SeidelS. EssmannC.L. Ephrin-B2 regulates VEGFR2 function in developmental and tumour angiogenesis.Nature2010465729748749110.1038/nature08995 20445540
    [Google Scholar]
  69. WangH.U. ChenZ.F. AndersonD.J. Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4.Cell199893574175310.1016/S0092‑8674(00)81436‑1 9630219
    [Google Scholar]
  70. AdamsR.H. AlitaloK. Molecular regulation of angiogenesis and lymphangiogenesis.Nat. Rev. Mol. Cell Biol.20078646447810.1038/nrm2183 17522591
    [Google Scholar]
  71. GeretyS.S. AndersonD.J. Cardiovascular ephrinB2 function is essential for embryonic angiogenesis.Development200212961397141010.1242/dev.129.6.1397 11880349
    [Google Scholar]
/content/journals/cpd/10.2174/0113816128374345250521115849
Loading
/content/journals/cpd/10.2174/0113816128374345250521115849
Loading

Data & Media loading...

Supplements

Supplementary material is available on the publisher's website along with the published article.

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test